What should be monitored regularly during therapy with Pradaxa?

Monitoring renal function regularly during therapy with Pradaxa (dabigatran) is crucial due to the drug's dependence on the kidneys for elimination. Pradaxa is an anticoagulant that requires careful dosing adjustments based on the patient's renal clearance. Impaired renal function can lead to increased drug levels in the body and a higher risk of bleeding, which is a significant concern with anticoagulants.

Regular assessments of renal function help healthcare providers determine whether the current dosage is appropriate or if an adjustment is necessary. For patients with reduced renal function, the prescribing guidelines typically recommend a lower dose or may suggest an alternative anticoagulant altogether, emphasizing the importance of renal monitoring to ensure both efficacy and safety during therapy.